Naltrexone is an opioid antagonist medication used to treat opioid use disorder and alcohol dependence. It works by blocking the euphoric and sedative effects of opioids, helping to prevent relapse and support long-term recovery.
Naltrexone is a medication used in the treatment of opioid and alcohol dependence. It is an opioid antagonist, which means it works by blocking the effects of opioids at their receptor sites in the brain. This action helps prevent the euphoric and sedative effects of opioids, making it a valuable tool in preventing relapse. Naltrexone is available in both oral and extended-release injectable forms, offering flexibility in treatment plans.
Naltrexone was first synthesized in the 1960s and initially investigated for its potential in treating opioid overdose. It was approved by the FDA for the treatment of opioid addiction in 1984 and later for alcohol dependence in 1994. Naltrexone’s approval marked a significant advancement in addiction treatment, providing a non-addictive option for preventing relapse in individuals recovering from opioid and alcohol dependence.
The development of the extended-release injectable form, known as Vivitrol, in the mid-2000s further expanded its utility. Vivitrol, which is administered once a month, improves adherence to treatment by eliminating the need for daily medication, which can be challenging for individuals struggling with addiction.
Naltrexone is a powerful medication for preventing relapse in individuals recovering from opioid and alcohol dependence. Its ability to block the effects of opioids and its non-addictive nature makes it a valuable component of comprehensive addiction treatment plans. At Athens Health, we incorporate naltrexone into our treatment programs to provide our clients with effective, flexible, and supportive care on their path to recovery.